TWENTY-ONE patients, including a teenager, could be at risk of HIV and hepatitis, after undergoing procedures with ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...

Health experts are sounding the alarm over viral hepatitis, a group of infectious diseases that can silently damage the liver ...

For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of ...

There is currently no cure for hepatitis B, but researchers are working on it. The unique structure of hepatitis B's DNA makes it hard to treat with antiviral drugs. New drugs are being tested to stop ...

Researchers have now identified bemnifosbuvir, a drug already in clinical trials for hepatitis C, as a possible way to stop ...

Combining HCV testing and treatment while in jail with connections to community services after release would reduce ...

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a ...